BB&T Investment Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$28K Sell
419
-327
-44% -$21K ﹤0.01% 705
2017
Q3
$49K Sell
746
-101
-12% -$6.38K 0.01% 528
2017
Q2
$54K Sell
847
-761
-47% -$45.7K 0.01% 455
2017
Q1
$95K Buy
1,608
+1
+0.1% +$58 0.04% 277
2016
Q4
$90K Buy
+1,607
New +$92.5K 0.07% 219

Other funds holding PJP

BB&T Investment Services's PJP Position: Q4 2017 in Review

BB&T Investment Services reduced its Invesco Pharmaceuticals ETF (PJP) stake by 44% in Q4 2017, selling an estimated $21K and leaving 419 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

BB&T Investment Services first reported a position in PJP in Q4 2016 and has held it in 5 quarters since. The position peaked at $95K in Q1 2017. 92 funds tracked by Wall St. Rank hold PJP as of Q4 2017.

  • BB&T Investment Services held 419 shares of Invesco Pharmaceuticals ETF worth $28K as of Q4 2017.
  • BB&T Investment Services sold 327 Invesco Pharmaceuticals ETF shares in Q4 2017, an estimated $21K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #705 holding.
  • BB&T Investment Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Invesco Pharmaceuticals ETF position peaked at $95K in Q1 2017.
  • 92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.